| Literature DB >> 29735560 |
Ursula Kaspar1, Jorge A de Haro Sautto2, Sonja Molinaro3, Georg Peters2, Evgeny A Idelevich2, Karsten Becker2.
Abstract
Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) isolates are increasingly migrating from livestock into human and animal health care settings. Alternative substances are needed to overcome the drawbacks of currently available drugs used for MRSA eradication. The recombinant bacteriophage endolysin HY-133 has proved to be an active agent against S. aureus Here, the in vitro activity of HY-133 was studied against a large collection of genetically diverse LA-MRSA isolates revealing its high activity against mecA-, mecB-, and mecC-positive LA-MRSA.Entities:
Keywords: LA-MRSA; Staphylococcus aureus; antimicrobial agents; bacteriophage therapy; endolysin; livestock; susceptibility testing
Mesh:
Substances:
Year: 2018 PMID: 29735560 PMCID: PMC6021658 DOI: 10.1128/AAC.00385-18
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191